Principal Investigator: Sotirios Parashos, MD, PhD
Study sponsor: Koneksa Health
Location: Neuroscience Center, Struthers Parkinson’s Center
Purpose of study: The Disease Progression Study is an observational study to evaluate detection of Parkinson’s progression, usability, compliance, validity, and reliability of digital assessments along with digital biomarker/eCOA discovery. The study
The Disease Progression Study part in Parkinson’s Disease has a duration of approximately 12 months.
Inclusion Criteria:
– Clinically established Parkinson’s disease
– 18-85 years of age
– BMI 18-40 kg/m2
Exclusion Criteria:
– Planning to enroll in a clinical trial for disease modifying therapy that will overlap with this trial
– Increased risk of falling (defined as >6 falls in last 12 months)
– Intracranial metallic/magnetic devises (such as a cochlear implant or deep brain stimulator)
– Implanted active device (such as a pacemaker or defibrillator)
Study Contact:
Renee Rosenberg
(651) 495-6363
ClinicalTrials@HealthPartners.com
